DK446388A - Pyrazinoxidforbindelse af nf-1616 -904 og farmaceutisk praeparat indeholdende denne - Google Patents

Pyrazinoxidforbindelse af nf-1616 -904 og farmaceutisk praeparat indeholdende denne

Info

Publication number
DK446388A
DK446388A DK446388A DK446388A DK446388A DK 446388 A DK446388 A DK 446388A DK 446388 A DK446388 A DK 446388A DK 446388 A DK446388 A DK 446388A DK 446388 A DK446388 A DK 446388A
Authority
DK
Denmark
Prior art keywords
pyrazinoxide
compound
pharmaceutical preparation
preparation containing
pharmaceutical
Prior art date
Application number
DK446388A
Other languages
English (en)
Other versions
DK446388D0 (da
DK170617B1 (da
Inventor
Yoshimasa Nakano
Michiharu Sugawara
Setsuyoshi Uetsuki
Taketoshi Izawa
Tomoyuki Kawaguchi
Akira Wada
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of DK446388D0 publication Critical patent/DK446388D0/da
Publication of DK446388A publication Critical patent/DK446388A/da
Application granted granted Critical
Publication of DK170617B1 publication Critical patent/DK170617B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/16—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing two or more hetero rings
    • C12P17/165—Heterorings having nitrogen atoms as the only ring heteroatoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Genetics & Genomics (AREA)
  • Urology & Nephrology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Reproductive Health (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK446388A 1987-08-11 1988-08-10 Pyrazinoxidforbindelse NF-1616-904, fremgangsmåde til fremstilling heraf og farmaceutiske præparater indeholdende denne DK170617B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP20153787 1987-08-11
JP20153787 1987-08-11

Publications (3)

Publication Number Publication Date
DK446388D0 DK446388D0 (da) 1988-08-10
DK446388A true DK446388A (da) 1989-02-12
DK170617B1 DK170617B1 (da) 1995-11-13

Family

ID=16442692

Family Applications (1)

Application Number Title Priority Date Filing Date
DK446388A DK170617B1 (da) 1987-08-11 1988-08-10 Pyrazinoxidforbindelse NF-1616-904, fremgangsmåde til fremstilling heraf og farmaceutiske præparater indeholdende denne

Country Status (9)

Country Link
US (1) US5021419A (da)
EP (1) EP0303250B1 (da)
JP (1) JPH01131177A (da)
KR (1) KR960005150B1 (da)
CN (1) CN1028655C (da)
DE (1) DE3880231T2 (da)
DK (1) DK170617B1 (da)
ES (1) ES2054748T3 (da)
MX (1) MX9202936A (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69029231T2 (de) 1989-02-10 1997-03-20 Otsuka Pharma Co Ltd Indolderivate, ihre herstellung und diese enthaltendes arzneimittel zum verhindern und behandeln von nephritis
US5238938A (en) * 1989-02-10 1993-08-24 Otsuka Pharmaceutical Co., Ltd. Indole derivatives
CA2067663A1 (en) * 1991-05-01 1992-11-02 Hitoshi Tone Pyrazine derivatives
SE529897C2 (sv) 2006-03-27 2007-12-27 Rottneros Ab Formpressat tråg

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8427735D0 (en) * 1984-11-02 1984-12-12 Fujisawa Pharmaceutical Co Piperazine compound

Also Published As

Publication number Publication date
US5021419A (en) 1991-06-04
DK446388D0 (da) 1988-08-10
JPH01131177A (ja) 1989-05-24
CN1028655C (zh) 1995-05-31
EP0303250A3 (en) 1990-07-11
DE3880231D1 (de) 1993-05-19
EP0303250A2 (en) 1989-02-15
KR960005150B1 (ko) 1996-04-22
MX9202936A (es) 1992-06-30
EP0303250B1 (en) 1993-04-14
DK170617B1 (da) 1995-11-13
ES2054748T3 (es) 1994-08-16
CN1032031A (zh) 1989-03-29
JPH0557273B2 (da) 1993-08-23
KR890003734A (ko) 1989-04-17
DE3880231T2 (de) 1993-10-07

Similar Documents

Publication Publication Date Title
DK263288A (da) Farmaceutisk praeparat af cefuroxim-axetil
DK170187A (da) Pharmaceutisk fordelagtigt salt af amlodipin og farmaceutiske praeparater indeholdende dette
DK404588A (da) Tetrahydrocabazol-1-alkansyre og farmaceutisk praeparat indeholdende en saadan forbindelse
DK51493D0 (da) Laegemiddel indeholdende humant interleukin-1alfa og anvendelse af interleukin-1alfa til fremstilling af et saadant laegemiddel
PT87237A (pt) Process for the preparation of bifunctional proteins and of pharmaceutical compounds containing them
DK522688D0 (da) Tricykliske amidinderivater og farmaceutiske praeparater med indhold af saadanne forbindelser
DK655288A (da) Diarylstyrylquinolindisyre og farmaceutisk praeparat indeholdende en saadan forbindelse
DK287188A (da) Cephalosporinforbindelser og farmaceutisk praeparat deraf
DK127588D0 (da) Beta-aminoethylsubstituerede phenylforbindelser, farmaceutiske praeparater indeholdende samme og fremgangsmaader til fremstilling af saadanne forbindelser
DK48886A (da) Akryl- eller heteroarylforbindelse og farmaceutisk praeparat indeholdende en saadan forbindelse
DK549688D0 (da) Fremstilling af peptider
DK522788D0 (da) Amidinoderivater og farmaceutiske praeparater med indhold af saadanne forbindelser
DK314386A (da) Quinoloncarboxyylsyreforbindelse og antibakterielle farmaceutiske praeparater indeholdende denne
DK270988D0 (da) Nitrogenholdige derivater af epipodophyllotoxinglucosider
DK119688D0 (da) 23-oxo- (-keto-) og 23-imino-derivater af mono- og diepoxy-ll-f28249-forbindelser
DK446388A (da) Pyrazinoxidforbindelse af nf-1616 -904 og farmaceutisk praeparat indeholdende denne
DK449188D0 (da) 2'-deoxy-5-fluoruridinderivater og farmaceutiske praeparater med indhold af saadanne forbindelser
DK97388A (da) Mellemprodukt og fremgangsmaade til fremstilling af antihypercholestrolemiske tetrazolforbindelser
DK701588A (da) N-hydroxy-5-phenyl-2-furancarboximidamider og anvendelse heraf til fremstilling af farmceutiske praeparater
PT87593A (pt) Process for the preparation of nucleosides and of pharmaceutical compounds containing them
DK105089A (da) Fremstilling af bis(amin-holdige)benzendioler
DK489084A (da) Fremgangsmaade til udvinding af beta-elemonsyre og farmaceutisk praeparat indeholdende beta-elemonsyre
DK670588D0 (da) Farmaceutisk praeparat til behandling af phlebektasi og fremgangsmaade til fremstilling af praeparatet
NO861083L (no) Analogifremgangsmaate og fremstilling av imidazoisokinoliner og imidazo-tienopyridin-forbindelser.
IT1212039B (it) Procedimento di preparazione di priridobenzodiazepinone

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed